Insights on the Use of α-Lipoic Acid for Therapeutic Purposes.

Salehi B, Berkay Yılmaz Y, Antika G, Boyunegmez Tumer T, Fawzi Mahomoodally M, Lobine D, Akram M, Akram M, Riaz M, Capanoglu E, Sharopov F, Martins N, Cho WC, Sharifi-Rad J. · 2019

Read Insights on the Use of α-Lipoic Acid for Therapeutic Purposes. by Salehi B, Berkay Yılmaz Y, Antika G, Boyunegmez Tumer T, Fawzi Mahomoodally M, Lobine D, Akram M, Akram M, Riaz M, Capanoglu E, Sharopov F, Martins N, Cho WC, Sharifi-Rad J. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6723188.txt.

Introduction

Salehi and co-authors review alpha-lipoic acid and its medical uses. This sulfur compound occurs in plants, animals, and people. It works as a strong antioxidant and helps enzymes inside mitochondria. Doctors already use it for nerve pain linked to diabetes. Its benefit is capped by how poorly the body absorbs it.

Only about 30% reaches the blood, and it breaks down fast. The review covers new formulations that raise absorption, including liquid forms and special matrices. One mirror form of the molecule, the R form, performs better than the other. Better delivery could raise the compound's healing effect in several conditions.

Catalog record

CREATORSalehi B, Berkay Yılmaz Y, Antika G, Boyunegmez Tumer T, Fawzi Mahomoodally M, Lobine D, Akram M, Akram M, Riaz M, Capanoglu E, Sharopov F, Martins N, Cho WC, Sharifi-Rad J.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE91 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6723188

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Insights on the Use of α-Lipoic Acid for Therapeutic Purposes By Bahare Salehi, Yakup Berkay Yılmaz, Gizem Antika, Tugba Boyunegmez Tumer, Mohamad Fawzi Mahomoodally, Devina Lobine, Muhammad Akram, Muhammad Riaz, Esra Capanoglu, Farukh Sharopov, Natália Martins, William C Cho Published in: Biomolecules DOI: 10.3390/biom9080356 ABSTRACT Abstract α-lipoic acid (ALA, thioctic acid) is an organosulfur component produced from plants, animals, and humans. It has various properties, among them great antioxidant potential and is widely used as a racemic drug for diabetic polyneuropathy-associated pain and paresthesia. Naturally, ALA is located in mitochondria, where it is used as a cofactor for pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase complexes. Despite its various potentials, ALA therapeutic efficacy is relatively low due to its pharmacokinetic profile. Data suggests that ALA has a short half-life and bioavailability (about 30%) triggered by its hepatic degradation, reduced solubility as well as instability in the stomach. However, the use of various innovative formulations has greatly improved ALA bioavailability. The R enantiomer of ALA shows better pharmacokinetic parameters, including increased bioavailability as compared to its S enantiomer. Indeed, the use of amphiphilic matrices has capability to improve ALA bioavailability and intestinal absorption. Also, ALA’s liquid formulations are associated with greater plasma concentration and bioavailability as compared to its solidified dosage form. Thus, improved formulations can increase both ALA absorption and bioavailability, leading to a raise in therapeutic efficacy. Interestingly, ALA bioavailability will be dependent on age, while no difference has been found for gender. The present review aims to provide an updated on studies from preclinical to clinical trials assessing ALA’s usages in diabetic patients with neuropathy, obesity, central nervous system-related diseases and abnormalities in pregnancy. Keywords: α-lipoic acid, bioavailability, formulations, clinical trial, diabetic neuropathy, obesity, schizophrenia, sclerosis, pregnancy 1. INTRODUCTION α-lipoic acid (ALA), also known as 1,2-dithiolane-3-pentanoic acid or thioctic acid, is a compound commonly found in mitochondria, necessary for different enzymatic functions. ALA was isolated by Reed in 1951 [1] as an acetate replacing factor and its first clinical use dates from 1959 in the treatment of acute poisoning by Amanita phalloides, also known death cap (from mushrooms) [2]. Briefly, ALA is an organosulfur compound produced from plants, animals, and humans and exists in nature. In the Krebs cycle, ALA plays important roles in various chemical reactions, acting as a cofactor for some enzymatic complexes involved in energy generation for the cell. It also forms covalent bonds with proteins and has therapeutic potential. It has a single chiral center and asymmetric carbon which results in two optical isomers: R- and S- lipoic acid (Figure 1) [3]. Thus, ALA has two enantiomeric forms, called S and R enantiomers, considered mirror images of each other. Both S and R enantiomers are present equally in ALA, being however the R isomeric form present naturally, while the S isomer is prepared through chemical processes. Foods are a natural source of the R enantiomer, naturally produced inside the living organisms forming covalent bonds with proteins. While ALA exists in nature as R enantiomer, synthetic supplementation consists of a racemic composition of R and S forms [4]. Although synthetized by the human body at low amount, the ALA quantities produced are not enough to fulfill the energy requirement of the cell. Thus, it is mostly obtained from diet, especially from meat and vegetables. Fruits are also a source of this acid [5]. [Figure: The chemical structure of optical isomers of ALA.] On the other hand, ALA has numerous clinically valuable properties [5,6]. It acts as an enzymatic cofactor [7] and is also involved in glucose [8,9] and lipid [10] metabolism and manages gene transcription. ALA also acts as antioxidant because it not only improves but also restores the intrinsic antioxidant systems, and supports their production or cell accessibility [11,12,13]. It also efficiently removes heavy metals from blood stream, responsible for oxidative stress [11,13,14]. The most unique characteristic of ALA over other antioxidant substances is that it reacts as both lipid and water soluble compound [5,6]. There is no doubt that it is a strong antioxidant, but due to certain reasons its use for medicinal purposes is prohibited; however, in some states it is used as a supplement and in others as a remedy [5,6,15]. These restrictions are due to some endogenous characteristics of substance by itself, such as the changeableness due to the disclosing of dithiolane ring and the emergence of disulfide bond between molecules. Other properties that limit the oral use of ALA are its decreased ability to become dissolved in the gastrointestinal tract and increased rate of hepatic metabolism. In addition, besides it is widely known antioxidant potential, ALA has also many other functions, as it is its involvement in mitochondria producing energy, by acting as cofactor for various enzymes involved in metabolism [5]. Moreover, ALA plays a vital role in glucose humiliation during metabolism. For instance, ALA has been applied as a racemic medication for diabetic polyneuropathy-associated pain and paresthesia [16]. ALA has also an important function in energy transduction through mitochondria [6,17]. Two reduced or oxidized thiol groups are present in the small molecule of ALA. The oxidized form is known as ALA or simply as lipoic acid, while the reduced form is noted as dihydrolipoic acid (DHLA). ALA inactivates free radicals and the reduced form also interacts with reactive oxygen species (ROS) [8]. Naturally, ALA is found in mitochondria where it binds to the E2 subunit and is used as a cofactor for both pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase complexes [18]. ALA is synthesized de novo at very small amounts in the body from cysteine and fatty acids, because of which there is a need to supplement it from exogenous sources [19]. ALA improves the glycemic control [6], alleviates diabetes mellitus (DM) complications [20,21] and even symptoms of peripheral neuropathy, at same time that effectively lessens the heavy metals toxicity [22]. 1.1. Forms of Lipoic Acid 1.1.1. R-α-Lipoic Acid This isomer is present in nature, and is found in animals, plants and from human body. In nature, this is the form which ALA demonstrates its effects [23]. 1.1.2. S-α-Lipoic Acid This type of isomer is not present in the nature. It may be obtained through many chemical procedures of thioctic acid and stops the important activities of R-ALA, e.g., their interaction with genes, enzymes and proteins [23]. ALA is found in many vegetables (spinach, broccoli, tomato, brussels sprouts, and rice bran), meats and entrails (e.g., liver and kidney) in lipoyllysine form (ALA with binding lysine residues). Moreover, ALA can also be synthesized by enzymatic reactions in mitochondria from octanoic acid and cysteine (as a sulfur donor) [24,25]. Both ALA and DHLA have a determinant role in oxidative metabolism [26]. For instance, it has been shown that ALA or its reduced form, DHLA have several positive health benefits, including as biological antioxidants, metal chelators and detoxification agents, being also able to reduce the oxidized forms of other antioxidant agents, including glutathione, vitamins C and E, and to modulate various signaling pathways, such as insulin and nuclear factor kappa B (NF-κB) [27]. It has also been used for age-associated cardiovascular, cognitive, and neuromuscular deficits [28,29,30], to reform endothelial dysfunction [31], to decrease oxidative stress [32] and to inhibit the formation of

Read the complete text